FormDSignal
47

Click Therapeutics raises $50M in Regulation D offering

Company raise · Closed · NEW YORK, NY · Form D filed 2026-10-01

Click Therapeutics, a Delaware corporation in healthcare, closed a $50M Regulation D offering under exemption 6(b) with one investor. The offering closed on April 7, 2026, with all $50M committed.

Note: Offering closed with only one investor despite $50M total commitment, which is atypical for a raise of this size.

$10M+ raiseoperating_company

Why now — by persona

  • Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

David B. KleinExecutive Officer, Director
Randall StanickyExecutive Officer
Cris De LucaDirector
Jeffrey BerkowitzDirector
Alex ZissonDirector
Maria ForeroDirector
Muzammil MansuriDirector
Lezrene CunninghamMs. Cunningham served as a Director on the date that the board approved the Offering and on the Date of First Sale. She resigned prior to the date hereof.
David FriedmanDirector
Anthony CostelloDirector
Bruce RobertsonMr. Robertson was elected a Director after the Date of First Sale and resigned prior to the date hereof.
Douglas LangaMr. Langa was elected a Director after the Date of First Sale.

Signed by David B. Klein, President and Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer